Power3 Medical Products, Inc. (PWRM.OB)

This company specializes in the early detection of breast cancer, to improve the survival rates and quality of life for women with the disease.

Power3 Medical uses its Proteomic-based platform to analyze breast cancer at the protein level. To date, they have identified over 120 distinct biomarkers relating to breast cancer. In collaboration with a major research institute in Houston Texas, the Company has developed the Early Detection Breast Cancer Test, BC-SeraPro™. This test indicates, years prior to mammography, whether the patient has an early indication for breast cancer and if they require more testing or treatment. Power3 believes the BC-SeraPro Test™ will become the standard precursor to the mammogram. ( Read More http://crweselect.com/22255/stock-alerts/pwrm-orfg-hgsh-usat-bldp-crwese... )